Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Exkivity is a broad-spectrum inhibitor that broadly inhibits multiple mutant kin···【more】
Release date：2024-08-08Recommended：213
Exkivity is a new type of targeted therapy for lung cancer, which is a third rep···【more】
Release date：2024-08-08Recommended：209
Exkivity is a novel oral anti-cancer drug that acts as a small molecule tyrosine···【more】
Release date：2024-08-08Recommended：229
Capmatinib can be used to treat patients with METex14-mutated non-small cell lun···【more】
Release date：2024-08-07Recommended：207
Capmatinib is an oral MET inhibitor that received Breakthrough Therapy Designati···【more】
Release date：2024-08-07Recommended：191
Capmatinib is a targeted drug used to treat a specific type of non-small cell lu···【more】
Release date：2024-08-07Recommended：241
Capmatinib acts as a targeted therapy to stop the growth and spread of cancer ce···【more】
Release date：2024-08-07Recommended：188
Exkivity is a targeted drug for the treatment of specific types of non-small cel···【more】
Release date：2024-08-07Recommended：192
Exkivity is an oral capsule drug primarily used for the treatment of patients wi···【more】
Release date：2024-08-07Recommended：235
Exkivity is an innovative, oral, small molecule tyrosine kinase inhibitor (TKI) ···【more】
Release date：2024-08-07Recommended：201
Exkivity offers a new treatment option for NSCLC patients with EGFR exon 20 inse···【more】
Release date：2024-08-07Recommended：187
Capmatinib is a targeted drug manufactured by Novartis for the treatment of adul···【more】
Release date：2024-08-07Recommended：182
